InspireMD launches USD75m at-the-market equity offering
Categories: Capital Markets
InspireMD announced an “at-the-market” equity offering program for the sale of up to USD 75 million of common stock. Shares may be sold on Nasdaq or through other lawful methods, with BTIG acting as sales agent. The company said it intends to use net proceeds for operations, including research and development, sales and marketing, working capital, and general corporate purposes.
Greenberg Traurig served as counsel to InspireMD on the offering, and Paul Hastings represented BTIG in connection with the ATM program.
The Greenberg Traurig Capital Markets team was led by Corporate shareholders Raffael Fiumara, Sami Ghneim, Gary Emmanuel, and Michael Soumas, and Corporate associates Cesar Fischer and Sergio Shapiro.
